BioScale
The company is developing a proteomic test for chronic obstructive pulmonary disease that it plans to launch in early 2018 as a CLIA-based diagnostic.
Meso Scale Discovery has released its S-PLEX immunoassay platform, which, the company said, is 1,000 times more sensitive than existing ELISA technologies and can detect analytes at concentrations below 1 femtogram per mL.
BioScale Raises $18.8M; Targets $38.3M
NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said in a regulatory document that it has raised $18.8 million of a targeted $38.3 million financing round.
Biotech firm BioScale presented data this week at the Society of Laboratory Automation and Screening annual meeting in Orlando demonstrating the ability of its acoustic membrane microparticle technology to quantify levels of multiple cytokines in serum and plasma.
The California Institute of Technology of Pasadena has received US Patent No. 8,354,231, "Methods and systems for detecting and/or sorting targets." The methods provided are based on the combined use of polynucleotide-encoded protein and substrate polynucleotides.
Jun 15, 2012
People in the News: Jun 15, 2012
Oct 14, 2011
Movers & Shakers: Oct 14, 2011
Premium
Jan 14, 2011
Oct 15, 2010
Movers & Shakers: Oct 15, 2010
Premium
Jun 14, 2010
Protein Analytics Firm BioScale Raises $25M
Dec 15, 2009